Ajay Madan's Insider Trades & SAST Disclosures
Ajay Madan's most recent trade in Therealreal Inc was a trade of 51,425 Common Stock done at an average price of $5.8 . Disclosure was reported to the exchange on March 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ajay Madan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Therealreal Inc | Gopal Ajay Madan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 18 Mar 2025 | 51,425 | 1,275,773 (1%) | 0% | 5.8 | 299,376 | Common Stock |
| Therealreal Inc | Gopal Ajay Madan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.90 per share. | 20 Feb 2025 | 102,386 | 1,327,198 (1%) | 0% | 6.9 | 706,013 | Common Stock |
| Therealreal Inc | Gopal Ajay Madan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 179,584 | 1,429,584 (1%) | 0% | 0 | Common Stock | |
| Therealreal Inc | Gopal Ajay Madan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 700,000 | 1,250,000 (1%) | 0% | 0 | Common Stock | |
| Therealreal Inc | Gopal Ajay Madan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 550,000 | 550,000 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Ajay Madan | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 65,400 | 65,400 | - | - | Common Stock (right to buy) | |
| Crinetics Pharmaceuticals Inc | Ajay Madan | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 13,950 | 185,995 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharmaceuticals Inc | Ajay Madan | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 19.88 per share. | 28 Feb 2022 | 9,000 | 176,995 (0%) | 0% | 19.9 | 178,920 | Common Stock |
| Crinetics Pharmaceuticals Inc | Ajay Madan | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 17.83 per share. | 07 Feb 2022 | 13,411 | 172,045 (0%) | 0% | 17.8 | 239,085 | Common Stock |
| Crinetics Pharmaceuticals Inc | Ajay Madan | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2021 | 106,383 | 0 | - | - | Stock Option (right to buy) | |
| Crinetics Pharmaceuticals Inc | Ajay Madan | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.73 per share. | 28 Oct 2021 | 106,383 | 184,671 (0%) | 0% | 0.7 | 77,660 | Common Stock |
| Crinetics Pharmaceuticals Inc | Ajay Madan | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 131,000 | 131,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges